USP5 and neoplasm: We have found that the use of the USP5 inhibitor EOAI3402143, especially when combined with chemotherapy agents 5-FU and CDDP, can significantly suppress angiogenesis and tumor growth, and this therapeutic strategy has superior efficacy compared with 5-FU/CDDP alone.